Skip to content
1887

Journal of General Virology header logo Journal of General Virology

Volume 91, Issue 10

Hepatitis B doubly spliced protein, generated by a 2.2 kb doubly spliced hepatitis B virus RNA, is a pleiotropic activator protein mediating its effects via activator protein-1- and CCAAT/enhancer-binding protein-binding sites No Access

Abstract

The 2.2 kb doubly spliced defective hepatitis B virus (HBV) genome is frequently detected in the serum of patients with chronic hepatitis B. However, the biological significance of this type of defective genome is not well understood. In this study, expression of the hepatitis B doubly spliced protein (HBDSP) was confirmed from the 2.2 kb doubly spliced defective HBV genome, which was isolated and transfected into Huh-7 hepatoma cells. To explore the potential pathogenicity of HBDSP, hepatocellular proteins interacting with HBDSP were screened by a yeast two-hybrid assay. Unexpectedly, HBDSP could transactivate the GAL4-responsive element, and deletion mapping revealed that the fragment located between residues Leu-48 and Gln-75 of HBDSP was crucial for transactivation activity. In Huh-7 hepatoma cells, HBDSP localized predominantly to the cytoplasm and showed transactivating effects on the cytomegalovirus immediate-early promoter, simian virus 40 enhancer/promoter and HBV regulatory elements including the S1 promoter, S2 promoter, Enhancer I and core upstream regulatory sequences. Further studies revealed that the transactivating activities were mediated by activator protein-1- and CCAAT/enhancer-binding protein-binding sites. These findings suggest that HBDSP is a pleiotropic activator protein that can potentially serve as an HBV virulence factor.

  • Received:
  • Accepted:
  • Published Online:
© SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.022517-0
2010-10-01
2025-07-10
Loading full text...

Full text loading...

References

  1. Bradley, D. W.(1999). Hepatitis viruses: their role in human cancer. Proc Assoc Am Physicians 111, 588–593.[CrossRef] [Google Scholar]
  2. Dikstein, R., Faktor, O. & Shaul, Y.(1990). Hierarchic and cooperative binding of the rat liver nuclear protein C/EBP at the hepatitis B virus enhancer. Mol Cell Biol 10, 4427–4430. [Google Scholar]
  3. Günther, S., Li, B. C., Miska, S., Krüger, D. H., Meisel, H. & Will, H.(1995). A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69, 5437–5444. [Google Scholar]
  4. Günther, S., Sommer, G., Iwanska, A. & Will, H.(1997). Heterogeneity and common features of defective hepatitis B virus genomes derived from spliced pregenomic RNA. Virology 238, 363–371.[CrossRef] [Google Scholar]
  5. Hildt, E., Saher, G., Bruss, V. & Hofschneider, P. H.(1996). The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 225, 235–239.[CrossRef] [Google Scholar]
  6. Hildt, E., Munz, B., Saher, G., Reifenberg, K. & Hofschneider, P. H.(2002). The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J 21, 525–535.[CrossRef] [Google Scholar]
  7. Hu, J., Roy, S. K., Shapiro, P. S., Rodig, S. R., Reddy, S. P., Platanias, L. C., Schreiber, R. D. & Kalvakolanu, D. V.(2001). ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-β-dependent gene transcription in response to interferon-γ. J Biol Chem 276, 287–297.[CrossRef] [Google Scholar]
  8. Huang, Q., Wang, L., Bai, S., Lin, W., Chen, W., Lin, J. & Lin, X.(2009). Global proteome analysis of hepatitis B virus expressing human hepatoblastoma cell line HepG2. J Med Virol 81, 1539–1550.[CrossRef] [Google Scholar]
  9. Hunt, C. M., McGill, J. M., Allen, M. I. & Condreay, L. D.(2000). Clinical relevance of hepatitis B viral mutations. Hepatology 31, 1037–1044.[CrossRef] [Google Scholar]
  10. Ishida, H., Udea, K., Ohkawa, K., Kanazawa, Y., Hosui, A., Nakanishi, F., Mita, E., Kasahara, A., Sasaki, Y. & other authors(2000). Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II. J Virol 74, 1241–1251.[CrossRef] [Google Scholar]
  11. Karin, M., Liu, Z. & Zandi, E.(1997). AP-1 function and regulation. Curr Opin Cell Biol 9, 240–246.[CrossRef] [Google Scholar]
  12. Lee, D. H., Choi, B. H. & Rho, H. M.(1999). The synergistic transactivation of the hepatitis B viral (HBV) pregenomic promoter by the E6 protein of human papillomavirus type 16 (HPV-16 E6) with HBV X protein was mediated through the AP-1 site of E element in the enhancer I (EnI) in human liver cell. Biochem Biophys Res Commun 265, 62–66.[CrossRef] [Google Scholar]
  13. Lei, S., Pulakat, L. & Gavini, N.(1999). Genetic analysis of nif regulatory genes by utilizing the yeast two-hybrid system detected formation of a NifL–NifA complex that is implicated in regulated expression of nif genes. J Bacteriol 181, 6535–6539. [Google Scholar]
  14. Li, N. & Klaassen, C. D.(2004). Role of liver-enriched transcription factors in the down-regulation of organic anion transporting polypeptide 4 (oatp4; oatplb2; slc21a10) by lipopolysaccharide. Mol Pharmacol 66, 694–701. [Google Scholar]
  15. Lin, X., Yuan, Z. H., Wu, L., Ding, J. P. & Wen, Y. M.(2001). A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency. J Virol 75, 11827–11833.[CrossRef] [Google Scholar]
  16. Lopez-Cabrera, M., Letovsky, J., Hu, K. Q. & Siddiqui, A.(1991). Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus. Virology 183, 825–829.[CrossRef] [Google Scholar]
  17. Mancini-Bourgine, M., Bayard, F., Soussan, P., Deng, Q., Lone, Y. C., Kremsdorf, D. & Michel, M. L.(2007). Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients. J Virol 81, 4963–4972.[CrossRef] [Google Scholar]
  18. Moolla, N., Kew, M. & Arbuthnot, P.(2002). Regulatory elements of hepatitis B virus transcription. J Viral Hepat 9, 323–331.[CrossRef] [Google Scholar]
  19. Nakatake, H., Chisaka, O., Yamamoto, S., Matsubara, K. & Koshy, R.(1993). Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication. Virology 195, 305–314.[CrossRef] [Google Scholar]
  20. Nijhara, R., Jana, S. S., Goswami, S. K., Rana, A., Majumdar, S. S., Kumar, V. & Sarkar, D. P.(2001). Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo. J Virol 75, 10348–10358.[CrossRef] [Google Scholar]
  21. Preiss, S., Littlejohn, M., Angus, P., Thompson, A., Desmond, P., Lewin, S. R., Sasadeusz, J., Matthews, G., Dore, G. J. & other authors(2008). Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance. Hepatology 48, 741–749.[CrossRef] [Google Scholar]
  22. Raney, A. K., Zhang, P. & McLachlan, A.(1995). Regulation of transcription from the hepatitis B virus large surface antigen promoter by hepatocyte nuclear factor 3. J Virol 69, 3265–3272. [Google Scholar]
  23. Rosmorduc, O., Petit, M. A., Pol, S., Capel, F., Bortolotti, F., Berthelot, P., Brechot, C. & Kremsdorf, D.(1995).In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA. Hepatology 22, 10–19. [Google Scholar]
  24. Rossner, M. T.(1992). Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator. J Med Virol 36, 101–117.[CrossRef] [Google Scholar]
  25. Soussan, P., Garreau, F., Zylberberg, H., Ferray, C., Brechot, C. & Kremsdorf, D.(2000).In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J Clin Invest 105, 55–60.[CrossRef] [Google Scholar]
  26. Soussan, P., Tuveri, R., Nalpas, B., Garreau, F., Zavala, F., Masson, A., Pol, S., Brechot, C. & Kremsdorf, D.(2003). The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis. J Hepatol 38, 343–348. [Google Scholar]
  27. Twu, J. S. & Schloemer, R. H.(1987). Transcriptional trans-activating function of hepatitis B virus. J Virol 61, 3448–3453. [Google Scholar]
/content/journal/jgv/10.1099/vir.0.022517-0
Loading
Hepatitis B doubly spliced protein, generated by a 2.2 kb doubly spliced hepatitis B virus RNA, is a pleiotropic activator protein mediating its effects via activator protein-1- and CCAAT/enhancer-binding protein-binding sites
J. Gen. Virol. 91, 2592 (2010); https://doi.org/10.1099/vir.0.022517-0
/content/journal/jgv/10.1099/vir.0.022517-0
/content/journal/jgv/10.1099/vir.0.022517-0
Loading

Data & Media loading...

Supplements

vol. , part 10, pp. 2592 - 2600

Sequences of PCR primers used in this study

Sequences of oligonucleotides used for construction of reporter plasmids [Single PDF file](21 KB)

 

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error